Advanced Search
Share
July - September 2018
Journal Information
Previous Issue | Next Issue
Issue
Vol. 40. Issue 3.
Pages 199-292 (July - September 2018)
Scientific comments
Age and cytogenetic abnormalities
Cármino Antonio de Souza
Hematol Transfus Cell Ther. 2018;40:199
Open access
Original articles
Epidemiological and cytogenetic profiles of patients with hematological malignancies and their relationship with aging
Angelica de Souza Batista Maia Alves, Fernanda Barbi Bataglia, Luciene de Oliveira Conterno, Rosimeire Segato, Spencer Luiz Marques Payão
Hematol Transfus Cell Ther. 2018;40:200-6
Open access
Barriers experienced in self-care practice by young people with sickle cell disease
Sumaya Giarola Cecilio, Sônia Aparecida dos Santos Pereira, Valquíria dos Santos Pinto, Heloísa de Carvalho Torres
Hematol Transfus Cell Ther. 2018;40:207-12
Open access
Quantification of peripheral blood CD34+ cells prior to stem cell harvesting by leukapheresis: a single center experience
Natália Emerim Lemos, Mariela Granero Farias, Francyne Kubaski, Luciana Scotti, Tor Gunnar Hugo Onsten, Letícia de Almeida Brondani, Sandrine Comparsi Wagner, Leo Sekine
Hematol Transfus Cell Ther. 2018;40:213-8
Open access
Helicobacter pylori associated to unexplained or refractory iron deficiency anemia: an Egyptian single-center experience
Doaa M. El Demerdash, Heba Ibrahim, Dina M. Hassan, Heba Moustafa, Nehad M. Tawfik
Hematol Transfus Cell Ther. 2018;40:219-25
Open access
Translation, and interobserver and test–retest reliability of the Brazilian Portuguese version of Children's Hospital Oakland Hip Evaluation Scale for patients with sickle cell disease
Nágela Rayanne Barros de Freitas, Natalia Duarte Pereira, Maisa Santos Pessoa, Fábio Galvão, Sara Teresinha Olala Saad, Camila Tatiana Zanoni
Hematol Transfus Cell Ther. 2018;40:226-32
Open access
The influence of cell concentration at cryopreservation on neutrophil engraftment after autologous peripheral blood stem cell transplantation
Olga Margareth Wanderley de Oliveira Félix, Gisela Tunes, Valéria Cortez Ginani, Paulo César Simões, Daniele Porto Barros, Elizabete Delbuono, Maria Teresa de Seixas Alves, Antonio Sérgio Petrilli, ... Adriana Seber
Hematol Transfus Cell Ther. 2018;40:233-9
Open access
The frequency of oral conditions detected in hematology inpatients
Alessandra Oliveira Ferrari Gomes, Arley Silva Junior, Cesar Werneck Noce, Marisa Ferreira, Angelo Maiolino, Sandra Regina Torres
Hematol Transfus Cell Ther. 2018;40:240-4
Open access
Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group
Juliano Júlio Cerci, Mateos Bogoni, Valeria Buccheri, Elba Cristina Sá de Camargo Etchebehere, Talita Maira Bueno da Silveira, Otavio Baiocchi, Carlos de Araujo Cunha Pereira Neto, Marcelo Tatit Sapienza, ... Celso Dario Ramos
Hematol Transfus Cell Ther. 2018;40:245-9
Open access
Risk of Zika virus transmission by blood donations in Brazil
Mariana Munari Magnus, Danillo Lucas Alves Espósito, Victor Antonio da Costa, Priscila Silva de Melo, Carolina Costa-Lima, Benedito Antonio Lopes da Fonseca, Marcelo Addas-Carvalho
Hematol Transfus Cell Ther. 2018;40:250-4
Open access
Guidelines
Guidelines on myelodysplastic syndromes: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Silvia Maria Meira Magalhães, Lígia Niero-Melo, Maria de Lourdes Lopes Ferrari Chauffaille, Elvira Deolinda Rodrigues Pereira Velloso, Irene Lorand-Metze, Renata Buzzini, Wanderley Marques Bernardo
Hematol Transfus Cell Ther. 2018;40:255-61
Open access
Part 2: Myelodysplastic syndromes – classification systems
Irene Lorand-Metze, Lígia Niero-Melo, Renata Buzzini, Wanderley Marques Bernardo
Hematol Transfus Cell Ther. 2018;40:262-6
Open access
Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
Elvira Deolinda Rodrigues Pereira Velloso, Silvia Maria Meira Magalhães, Maria de Lourdes Lopes Ferrari Chauffaille, Renata Buzzini, Wanderley Marques Bernardo
Hematol Transfus Cell Ther. 2018;40:267-73
Open access
Part 4: Myelodysplastic syndromes—Treatment of low-risk patients with the 5q deletion
Silvia Maria Meira Magalhães, Elvira Deolinda Rodrigues Pereira Velloso, Renata Buzzini, Wanderley Marques Bernardo
Hematol Transfus Cell Ther. 2018;40:274-7
Open access
Part 5: Myelodysplastic syndromes—Treatment of high-risk disease
Silvia Maria Meira Magalhães, Maria de Lourdes Lopes Ferrari Chauffaille, Elvira Deolinda Rodrigues Pereira Velloso, Renata Buzzini, Wanderley Marques Bernardo
Hematol Transfus Cell Ther. 2018;40:278-82
Open access
Review article
Chagasic infection among blood donors in Brazil: an integrative review
Darwin Renne Florencio Cardoso, Léia Madeira Saboia dos Reis, Ranieri Flávio Viana de Sousa, Elaine Ferreira do Nascimento, Jéssica Pereira dos Santos, Filipe Aníbal Carvalho-Costa, Jacenir Reis dos Santos-Mallet
Hematol Transfus Cell Ther. 2018;40:283-91
Open access

Subscribe to our newsletter

Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Hematology, Transfusion and Cell Therapy